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DOI 10.1016/j.chembiol.2011.08.004Over the decades, scientists have dis-
covered several biomarkers suggestive of
disease risk; examples include lipid pro-
files or the presence of certain proteins.
Telome Health, a new company based in
Menlo Park, CA, is looking to market
another biomarker measurement based
on the science of telomeres.
Telomeres are long stretches of repeti-
tive DNA sequences found at the end
of chromosomes. Over the past several
years, epidemiological studies have
shown that telomeres shorten over time;
this finding by itself is akin to the fact that
hair grays as people age.Most compelling
is that these studies also suggest that
although telomere shortening is not diag-
nostic of a specific disease, individuals‘‘At some point, we expect that telomere length will be in-
corporated into cardiovascular risk scores or cancer risk
scores.’’ — Daniel Hunt, Telome Healthwith shorter telomeres are more likely to
experience loss of health, disease pro-
gression or more rapid disease progres-
sion, or mortality. ‘‘Many of these studies
show that for individuals who are in the
twenty-fifth or even the lower fiftieth
percentile for telomere length are at a
higher risk for disease, a future clinical
event, or death, compared to people in
theupper half or upper quartile of telomere
lengthmeasurements,’’ explains Calvin B.
Harley, pioneering telomere researcher
and now chief scientific officer at Telome
Health. The team at Telome Health is
building on these and other research
findings to offer a telomere length mea-
surement product.
Telomeres shorten each time chromo-
somes replicate as part of cell division,
and therefore they naturally shorten over
a lifetime. Large cross-sectional studies
show an average decline in telomere
length in populations of individuals from
newborns to centenarians. ‘‘But when
you look at the individual data there is a
lot of scatter,’’ says Harley. ‘‘That varia-tion between the norm and the individual
helps account for or predict the difference
in disease risk between individuals.’’
Nobel Prize Foundational Medicine
In the 1980s, Elizabeth Blackburn of the
University of California, San Francisco
(UCSF), copresented findings showing
that the repetitive telomere sequences
protect the ends of chromosomes from
degradation. In 2009, she was corecipient
of the Nobel Prize in Physiology and
Medicine for her contributions to this
science. Teaming with Calvin Harley and
two other UCSF researchers, Drs. Elissa
Epel and Jue Lin, Dr. Blackburn co-
founded Telome Health to pursue com-
mercial applications of this work.Telomerase is the enzyme that adds
telomeric DNA onto chromosome ends.
Some people who have extremely short
telomeres may have a disease condition
caused by a mutation in telomerase or
one of the telomere-associated proteins,
which are critical for telomere mainte-
nance. Individuals with a telomerase
mutation, however, are a rare population,
and this abnormality does not explain all
of the individuals with shortened telomere
lengths as compared to the cohort norms
established thus far.
Some individuals with short telomeres
may have inherited short telomeres, but
Drs. Blackburn, Epel, and Lin’s work
at UCSF has at least partially offered
another explanation: stress. In 2004,
the team published a paper in the
Proceedings of the National Academy of
Sciences which indicated that women
experiencing the chronic stress of pro-
viding care for disabled children and those
with long-term illness have higher oxida-
tive stress, shorter telomeres, and lower
telomerase activity (Epel et al., 2004).Chemistry & Biology 18, August 26, 2011Again, genetics alone did not explain the
findings, and the study pointed to stress
as a verifiable factor contributing to telo-
mere shortening. In subsequent papers,
Blackburn and Epel confirmed similar
findings in dementia caregivers (Epel
et al., 2010).
Adding to the knowledge of the biolog-
ical mechanisms underlying telomere
shortening, Epel and Blackburn and
colleagues recently published a paper
linking high levels of the proinflammatory
molecules IL-6 and TNFa with short
telomeres (O’Donovan et al., 2011).
Establishing the Norms
Just as lipid tests provide an absolute
number that must be compared with es-
tablished reference ranges to provide
meaningful results, telomere length mea-
surement in isolation does not provide
enough information. Well-researched,
large norms populations first need to be
rigorously created. ‘‘We are in the process
of defining the attributes to create the
best norms database for telomere length
in a US population,’’ says Daniel Hunt,
CEO of Telome Health. Other epidemio-
logical surveys have been done, with fairly
consistent findings.
Just this month, Dr. Blackburn’s labo-
ratory completed the largest telomere
measurement epidemiological study ever
conducted. The study was sponsored
by the National Institutes of Health and
was participated in by over 100,000
patients enrolled in the California-based
Kaiser Permanente healthcare system.
The average age of study participants
was 65 years old.
Telome Health aims to develop a norms
database of telomere length consisting of
a normal, healthy population, purposely
excluding as much as possible those
with disease, on multiple medications, or
otherwise in poor health. ‘‘We want to
establish norms that focus on a healthy
disease-free population, especially in the
30-80 year old age groups,’’ says Hunt,
who adds that the most meaningful infor-
mation will come when a measurement isª2011 Elsevier Ltd All rights reserved 937
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tion, not just the average population.
Autumn 2011 Commercial Entry
Currently, TelomeHealth offers a telomere
measurement test for research purposes.
They receive samples from companies
interested in knowing whether their pro-
duct (such as dietary supplements) helps
maintain or increase telomere length.
Others are hoping to prove that lifestyle
changes, stress reduction, or a specific
exercise program will be causally linked
to increased telomere length and are
using the test for their own corporate
research purposes.
Telome Health hopes to achieve CLIA
certification by October or November
2011 to market the assay to physicians.
‘‘A growing number of individuals.are
very health-conscience and [are] taking
charge of their own health monitoring
using new technologies, like the personal
genome test,’’ says Harley. The company
will not claim that the assay will be diag-
nostic of current or pending disease;
however, it will provide an absolute
measurement of telomere length and
a percentile based on the Telome Health
norms. Results will be provided to the
physician, not direct to the consumer,
and the results will not be part of amedical
diagnosis or interpretation. To educate
physicians who are ordering the assay
about telomere biology, Telome Health
further plans to have an active physician
education campaign and materials avail-
able for physicians and customers.
Telome Health is also in discussion
with pharmaceutical companies to design
studies that would validate the use of
telomere length as a potential diagnostic
and as a product that may be used in
drug development to stratify patients, to
validate certain theories about disease,
or to determine whether specific drugs’
effects (positive or negative) are related
to an individual patient’s telomere
biology.
The company obtained a worldwide
exclusive license to the University of
Utah’s quantitative PCR (qPCR) measure-
ment as the basis for its product. ‘‘We
did that because it is the dominant and
most scalable test available,’’ explains
Harley, ‘‘and the vast majority of the large
epidemiological studies that established938 Chemistry & Biology 18, August 26, 2011the clinical relationships between telo-
mere length and health have used qPCR,
which is a robust platform in itself.’’
Looking Forward
Telomere length can shorten dramatically,
but it can get longer as well. What has
not been established yet is a direct causal
relationship between longer telomere
length and people who exercise, eat a
good diet, and have low stress and
whether an unhealthy lifestyle drives telo-
mere shortening. To determine this, large
interventional studies need to be done to
establish causation.
‘‘In a fair number of the studies done,
telomere length tells us something differ-
ent [from] conventional biomarkers,’’ says
Harley. ‘‘The studies show that short telo-
meres are an independent risk factor and
in some cases are more predictive than
conventional markers.’’ He cites two large
cardiovascular disease (CVD) studies that
included measurements of lipids, C-reac-
tive protein, blood pressure, glucose,
body mass index, and other markers for
CVD risk (Brouilette et al., 2007; Bekaert
et al., 2007).
In a 2010 article in the Journal of the
American Medical Association, UCSF
researchers and colleagues showed that
individuals with CVD who take omega-3
fish oils had longer telomeres than
those with CVD who did not take the
supplement (Farzaneh-Far et al., 2010).
This data may indicate, in part, a mecha-
nism that explains why individuals with
heart disease who have increased dietary
intake of fish oils demonstrate longer
survival.
Taken together, these results do not yet
mean telomere length will replace estab-
lished markers, but Telome Health hopes
that it becomes one of several validated
biomarkers used in combination with
others. ‘‘There are upwards of 160 million
cholesterol tests done each year in the
United States,’’ says Harley. ‘‘At some
point, we expect that telomere length
will be incorporated into risk scores for
cardiovascular disease, cancer, and other
conditions.’’
‘‘But we first need to do the interven-
tional studies in the cardiovascular dis-
ease space stratifying patients based on
their telomere length,’’ explains Hunt of
the company’s interest in developingª2011 Elsevier Ltd All rights reserveda test that could be used as a diagnostic.
‘‘This informationmight be used to assess
inclusion in clinical trials or whether those
patients are eligible for a certain type of
intervention that otherwise might not be
cost-effective.’’ It might inform interven-
tional strategies for physicians either in
combination with drug regimens or even
without them.
Telome Health is not alone in its pursuit
of a commercial telomere measurement
test. Several other companies are pro-
viding telomere length testing: Repeat
Diagnostics of Vancouver, Canada; Spec-
traCell Laboratories based in Texas;
and the Spanish company Life Length.
At least one company, T.A. Sciences,
offers a telomerase activating dietary
supplement licensed from Geron Corpo-
ration to aid in telomere maintenance.REFERENCES
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